Department of Anesthesiology, Medical College of Wisconsin, Milwaukee, WI, USA.
Zablocki Veterans Affairs Medical Center, Milwaukee, WI, USA.
Mol Pain. 2020 Jan-Dec;16:1744806920963807. doi: 10.1177/1744806920963807.
The monosodium iodoacetate knee osteoarthritis model has been widely used for the evaluation of osteoarthritis pain, but the pathogenesis of associated chronic pain is not fully understood. The T-type calcium channel 3.2 (Ca3.2) is abundantly expressed in the primary sensory neurons, in which it regulates neuronal excitability at both the somata and peripheral terminals and facilitates spontaneous neurotransmitter release at the spinal terminals. In this study, we investigated the involvement of primary sensory neuron-Ca3.2 activation in monosodium iodoacetate osteoarthritis pain. Knee joint osteoarthritis pain was induced by intra-articular injection of monosodium iodoacetate (2 mg) in rats, and sensory behavior was evaluated for 35 days. At that time, knee joint structural histology, primary sensory neuron injury, and inflammatory gliosis in lumbar dorsal root ganglia, and spinal dorsal horn were examined. Primary sensory neuron-T-type calcium channel current by patch-clamp recording and Ca3.2 expression by immunohistochemistry and immunoblots were determined. In a subset of animals, pain relief by Ca3.2 inhibition after delivery of Ca3.2 inhibitor TTA-P2 into sciatic nerve was investigated. Knee injection of monosodium iodoacetate resulted in osteoarthritis histopathology, weight-bearing asymmetry, sensory hypersensitivity of the ipsilateral hindpaw, and inflammatory gliosis in the ipsilateral dorsal root ganglia, sciatic nerve, and spinal dorsal horn. Neuronal injury marker ATF-3 was extensively upregulated in primary sensory neurons, suggesting that neuronal damage was beyond merely knee-innervating primary sensory neurons. T-type current in dissociated primary sensory neurons from lumbar dorsal root ganglia of monosodium iodoacetate rats was significantly increased, and Ca3.2 protein levels in the dorsal root ganglia and spinal dorsal horn ipsilateral to monosodium iodoacetate by immunoblots were significantly increased, compared to controls. Perineural application of TTA-P2 into the ipsilateral sciatic nerve alleviated mechanical hypersensitivity and weight-bearing asymmetry in monosodium iodoacetate osteoarthritis rats. Overall, our findings demonstrate an elevated Ca3.2 expression and enhanced function of primary sensory neuron-T channels in the monosodium iodoacetate osteoarthritis pain. Further study is needed to delineate the importance of dysfunctional primary sensory neuron-Ca3.2 in osteoarthritis pain.
碘乙酸钠膝关节骨关节炎模型已广泛用于骨关节炎疼痛的评估,但与慢性疼痛相关的发病机制尚未完全阐明。T 型钙通道 3.2(Ca3.2)在初级感觉神经元中大量表达,在其中调节神经元在体和外周末端的兴奋性,并促进脊髓末端的自发性神经递质释放。在这项研究中,我们研究了初级感觉神经元-Ca3.2 激活在碘乙酸钠骨关节炎疼痛中的作用。通过向大鼠关节内注射碘乙酸钠(2mg)诱导膝关节骨关节炎疼痛,并在 35 天内评估感觉行为。此时,检查膝关节结构组织学、腰背部根神经节初级感觉神经元损伤和炎症性神经胶质增生,以及脊髓背角。通过膜片钳记录测定初级感觉神经元-T 型钙通道电流,通过免疫组化和免疫印迹测定 Ca3.2 表达。在一部分动物中,通过坐骨神经给药 Ca3.2 抑制剂 TTA-P2 缓解疼痛的情况进行了研究。膝关节注射碘乙酸钠导致骨关节炎组织病理学改变、对侧后肢负重不对称、同侧后爪感觉过敏和同侧背根神经节、坐骨神经和脊髓背角的炎症性神经胶质增生。初级感觉神经元中广泛上调神经元损伤标志物 ATF-3,表明神经元损伤不仅限于膝关节支配的初级感觉神经元。与对照组相比,来自碘乙酸钠大鼠腰背部根神经节的分离初级感觉神经元中的 T 型电流显著增加,并且免疫印迹法显示同侧背根神经节和脊髓背角中的 Ca3.2 蛋白水平显著增加。将 TTA-P2 经皮应用于同侧坐骨神经可缓解碘乙酸钠骨关节炎大鼠的机械性过敏和负重不对称。总的来说,我们的研究结果表明,在碘乙酸钠骨关节炎疼痛中,初级感觉神经元-Ca3.2 的表达水平升高,功能增强。需要进一步研究来阐明功能失调的初级感觉神经元-Ca3.2 在骨关节炎疼痛中的重要性。